Biotinylation and flow cytometry provide a viable, non-radioactive alternative for assessing platelet life span in bovine models for cardiovascular device testing.
Answers are grounded in this paper and cite their sources.
VAD implantation shortens platelet lifespan in calves; leaves open whether biotinylation enables reliable device testing in bovine models.
Reduced platelet life span is associated with the implantation of a variety of cardiovascular devices and may be used as a gauge of device biocompatibility. In the bovine model, platelet life span has previously been assessed with radioisotope labeling of removed platelets followed by reinjection and periodic gamma counting of blood samples. We report here the use of protein-reactive biotin (sulfo-N-hydroxysuccinimido [NHS]-biotin) as an alternative to radioisotope techniques whereby reinjected biotinylated platelets are subsequently detected in blood samples using phycoerythrin-streptavidin and flow cytometric techniques. Platelet life span was quantified in a normal calf (4.9 days) and in a calf prior to (6.1 days) and following (3.1 days) implantation of a Nimbus Axial Flow Pump ventricular assist device. The assessment of bovine platelet life span with biotinylation and flow cytometry avoids the technical, regulatory, and safety considerations associated with radioisotope usage and appears readily amenable to application in cardiovascular device testing.
No takes yet. Share an insight, caveat, or question.
Baker et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: